Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Affinity-based-purification-of-oligonucleotides-using-soluble-multimeric-oligonucleotides

 Recombinant avipox virus and immunological use thereof
What is claimed is: 1. A method for inducing an immunological response in a mammal to a mammalian ...


 HIV protease inhibitors useful for the treatment of AIDS
OF THE INVENTION AND PREFERRED EMBODIMENTS This invention is concerned with compounds of formula I,...


 Benzoxazinones as inhibitors of HIV reverse transcriptase
OF THE INVENTION AND PREFERRED EMBODIMENTS This invention is concerned with compounds of formula I,...


 HIV protease inhibitors useful for the treatment of AIDS
OF THE INVENTION AND PREFERRED EMBODIMENTS This invention is concerned with compounds of Formula I,...


 Continuously operational biological reactor
The present invention comprehends a continuously operable biological reactor for processing animal ...


 Separating epithelium from stroma in LASEK surgery
A surgical method according to the invention includes application of a solution containing ethanol ...


 Making a lightly oxidized starch additive by adding a cationic polymer to starch slurry prior to heating the slurry
We claim: 1. An improved process for making gelatinous cationic starch useful in surface sizing and ...


 Glucaric acid monoamides and their use to prepare poly(glucaramides)
OF THE INVENTION The novel alkali metal N-aminohydrocarbyl- and N-aminoheterohydrocarbyl-D-...


 Process for preparing poly (glucaramides)
OF THE INVENTION The novel alkali metal N-aminohydrocarbyl- and N-aminoheterohydrocarbyl-D-...


 Sheet supplying apparatus with centrally disposed feeding force
An object of the present invention is to provide a sheet supplying apparatus which can surely ...


 Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides

Details
Inventors: Agrawal, Sudhir; Habus, Ivan; Kandimalla, Ekambar R.;
Assignee: Hybridon, Inc. (Milford, MA)
Primary Examiner: Knode; Marian C.
Assistant Examiner: Crane; L. Eric
Attorney, Agent or Firm: McDonnell Boehnen Hulbert & Berghoff

The present invention provides novel compounds and methods for purifying oligonucleotides. The compounds according to the invention are multimeric oligonucleotides comprising a multimerization domain for inducing multimeric oligonucleotide aggregation, a hybridization domain that is complementary to a target oligonucleotide whose isolation is desired, and a linker domain connecting the multimerization domain and the hybridization domain. Other compounds of the invention comprise dendrimers having oligonucleotides with hybridization domains linked thereto. The methods of the invention comprise contacting the compounds of the invention with a solution containing a target oligonucleotide whose purification is desired. The target oligonucleotide hybridizes to the hybridization domain of the inventive compounds, thereby forming an aggregate. Synthetic failure sequences (N-1, N-2, etc.) and other oligonucleotides not complementary to the hybridization domain do not hybridize with the hybridization domain of the compounds and remain free in solution. Conventional size exclusion chromatography or small pore filter membranes are then used to separate the aggregate (and hence target oligonucleotide) from the other oligonucleotides. The aggregate is denatured and the target oligonucleotide separated once again by size exclusion chromatography or with a small pore filter membrane.

DETAILED DESCRIPTION The present invention provides novel multimeric oligonucleotides and their use for the purification of antisense oligonucleotides through complementary base recognition and size exclusion principles.
In a particular embodiment, the invention provides compounds and methods for the purification of full length synthetic oligonucleotides from a solution also containing N-1 and other failure sequences generated during synthesis.
The oligonucleotides of the invention are of a unique structure that allows them to hybridize specifically with a desired, full-length oligonucleotide and concomitantly form multimer aggregates.
The desired oligonucleotide is thereby bound in a multimer aggregate while other undesired oligonucleotides remain in solution.
The desired oligonucleotide is then separated and isolated using size-exclusion techniques.
In one aspect of the invention, the oligonucleotides according to the invention have at least three structural features: (1) a multimerization domain, (2) a hybridization domain, and (3) a linker domain.
The multimerization domain comprises a sequence of nucleotides that induces interoligonucleotide aggregate formation.
The hybridization domain comprises a sequence of nucleotides that is complementary to the 5' end of a synthetic oligonucleotide whose purification is desired.
The linker domain comprises a sequence of nucleotides or non-nucleotide chemical moieties and serves both to link the hybridization domain to the multimerization domain as well as space the hybridization domain away from the multimerization domain to allow for simultaneous aggregate formation and hybridization to the target oligonucleotide.
When contacted with a crude solution containing the desired oligonucleotide and other failure sequences generated during synthesis, the hybridization domain hybridizes to the desired ("target") oligonucleotide but not to the failure sequences, which are insufficiently complementary to hybridize to the hybridization domain under the conditions chosen



Related patents
  Substituted benzimidazole-, Benztriazole-, and benzimidazolone-O-glucosides
OF THE INVENTION All diabetics, regardless of their genetic and environmental backgrounds, have in common an apparent lack of insulin or inadequate insulin function. B...
  "Burst-free" sustained release poly-(lactide/glycolide) microspheres
OF THE INVENTION This invention relates to the design of biocompatible and biodegradable microspheres for novel, programmable sustained release of biologically active ...
  Neurospora expression system
What is claimed is: 1. A method of producing a mammalian peptide in a Neurospora fungus host, said method comprising: transforming by DNA uptake Neurospora spheroplasts ...
  Method of reducing bacterial proliferation
OF THE INVENTION Before the present invention is described, it is to be understood that this invention is not limited to particular embodiments described, as such may, ...
  Capillary membrane stabilization and reduction of tissue injury through use of IV biodegradable macromolecules with antioxidants and/or other chemicals
We claim: 1. Method of treating a human subject to prevent leakage of serum proteins from capillary endothelial junctions while simultaneously preventing the harmful ...
  Derivatives of monosaccharides as cell adhesion inhibitors
OF THE INVENTION The compounds of the present invention may be prepared by techniques well-known in the art and familiar to the average synthetic organic chemist. In ...
  Recombinant human papillomavirus type 18 vaccine
OF THE INVENTION The present invention is directed to DNA molecules encoding purified human papillomavirus type 18 (HPV type 18; HPV 18 ) and derivatives thereof. Such ...
  Synthetic HPV 16 virus-like particles
A series of synthetic virus-like particles useful in the characterization of human papillomavirus type 16 (HPV16) infection and assays employing the synthetic particles ...
  Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
What is claimed is: 1. An immunogenic composition suitable for administration by injection, which comprises antigenic determinants of at least two papillomavirus ...
  Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins
Methods of creating neoglycoproteins are provided that increase the cellular uptake of lysosomal enzymes and other glycoproteins by covalently attaching oligosaccharide ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved